Boehringer Ingelheim Pharmaceuticals, Inc. to Present 17 Abstracts at the Annual American Thoracic Society International Conference

Published: May 17, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- Boehringer Ingelheim will contribute to advancing the scientific discussion in respiratory disease at the American Thoracic Society International Conference (ATS 2013) in Philadelphia, PA, May 17 – 22. Data will highlight research conducted with a product approved for the treatment of chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® (tiotropium bromide inhalation powder)], as well as investigational compounds for asthma, idiopathic pulmonary fibrosis (IPF) and COPD.

Help employers find you! Check out all the jobs and post your resume.

Back to news